CDC and FDA recommend pause in use of J&J s Covid-19 vaccine
on Tuesday recommended a pause in the use of
Johnson & Johnson s (J&J s) single-dose Covid-19 vaccine after six people who received the vaccine developed a rare and severe type of blood clot called cerebral venous sinus thrombosis (CVST).
According to
STAT News, the blood clotting cases are similar to ones reported after use of AstraZeneca s Covid-19 vaccine, which FDA has not yet been authorized, and an adverse event reported during J&J s Covid-19 vaccine clinical trial in the United States, which led to the trial s temporary pause.
CDC and FDA recommend pause in use of J&J s Covid-19 vaccine
A panel just recommended FDA authorize Moderna s coronavirus vaccine. Here s what happens next.
FDA advisory panel on Thursday recommended the agency authorize the emergency use of
Moderna s coronavirus vaccine candidate a decision which makes it likely the inoculation will receive an emergency use authorization (EUA) as early as Friday.
On Thursday, members of FDA s
Vaccines and Related Biological Products Advisory Committee met to determine whether there is enough evidence to support an EUA for Moderna s coronavirus vaccine candidate. In a 20-0 vote, with one abstention, the committee concluded the vaccine appears to be safe and effective and recommended FDA authorize the vaccine s emergency use in people ages 18 and older.